Tonix Pharmaceuticals (TNXP) Short Interest Ratio & Short Volume $0.31 +0.00 (+0.81%) As of 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Tonix Pharmaceuticals Short Interest DataTonix Pharmaceuticals (TNXP) has a short interest of 4.00 million shares, representing 2.14% of the float (the number of shares available for trading by the public). This marks a 151.57% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 83.46 million shares to cover all short positions.Current Short Interest4,000,000 sharesPrevious Short Interest1,590,000 sharesChange Vs. Previous Month+151.57%Dollar Volume Sold Short$962,000.00Short Interest Ratio0.0 Days to CoverLast Record DateDecember 15, 2024Outstanding Shares186,894,000 sharesFloat Size186,890,000 sharesShort Percent of Float2.14%Today's Trading Volume82,445,122 sharesAverage Trading Volume83,463,680 sharesToday's Volume Vs. Average99% Short Selling Tonix Pharmaceuticals? Sign up to receive the latest short interest report for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTNXP Short Interest Over TimeTNXP Days to Cover Over TimeTNXP Percentage of Float Shorted Over Time Tonix Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/15/20244,000,000 shares $962,000.00 +151.6%2.1%0 $0.24 11/30/20241,590,000 shares $301,623.00 -69.5%0.9%0 $0.19 11/15/20245,220,000 shares $684,342.00 -31.9%2.8%0.1 $0.13 10/31/20247,670,000 shares $1.11 million +40.5%5.6%0.2 $0.15 10/15/20245,460,000 shares $769,860.00 -34.1%4.0%0.2 $0.14 9/30/20248,290,000 shares $1.23 million +1,674.4%6.0%0.3 $0.15 Get the Latest News and Ratings for TNXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 9/15/2024467,200 shares $73,256.96 -70.2%0.3%0 $0.16 8/31/20241,570,000 shares $359,530.00 +20.8%7.1%0.1 $0.23 8/15/20241,300,000 shares $593,840.00 +132.0%5.9%0.1 $0.46 7/31/2024560,400 shares $278,014.44 +30.5%2.7%0.3 $0.50 7/15/2024429,600 shares $256,385.28 -76.0%2.5%0.3 $0.60 6/30/20241,790,000 shares $1.25 million +1.7%18.2%1.6 $0.70 6/15/20241,760,000 shares $2.02 million +7,025.5%58.9%3.8 $1.15 5/31/202424,700 shares $128,756.16 -96.9%0.8%0.2 $5.21 5/15/2024785,600 shares $143,450.56 -50.9%0.8%0.3 $0.18 4/30/20241,600,000 shares $287,040.00 +7.4%1.9%0.7 $0.18 4/15/20241,490,000 shares $217,391.00 +19.2%1.8%0.7 $0.15 3/31/20241,250,000 shares $232,500.00 +29.3%1.5%0.6 $0.19 3/15/2024967,000 shares $310,407.00 +56.9%1.2%0.6 $0.32 2/29/2024616,200 shares $233,046.84 +3.3%0.8%0.3 $0.38 2/15/2024596,500 shares $230,249.00 -6.5%0.7%0.3 $0.39 1/31/2024638,200 shares $204,224.00 +132.1%0.8%0.4 $0.32 1/15/2024275,000 shares $81,455.00 -20.4%0.3%0.2 $0.30 12/31/2023345,300 shares $139,155.90 -77.0%0.6%0.3 $0.40 12/15/20231,500,000 shares $857,700.00 +308.7%5.6%1.4 $0.57 11/30/2023367,000 shares $190,106.00 +270.0%1.5%0.7 $0.52 11/15/202399,200 shares $46,723.20 -70.1%0.4%0.3 $0.47 10/31/2023331,600 shares $195,644.00 +21.2%1.2%1.1 $0.59 10/15/2023273,600 shares $159,727.68 -31.4%1.0%0.6 $0.58 9/30/2023398,700 shares $217,291.50 +277.9%2.3%0.9 $0.55 9/15/2023105,500 shares $97,060.00 -65.5%0.6%0.3 $0.92 8/31/2023305,600 shares $295,331.84 -33.3%1.7%0.7 $0.97 8/15/2023458,200 shares $439,093.06 -71.5%2.6%1 $0.96 7/31/20231,610,000 shares $1.72 million +12.6%15.0%3.4 $1.07 7/15/20231,430,000 shares $2.52 million -4.7%13.9%5.3 $1.76 6/30/20231,500,000 shares $2.37 million +32.7%14.5%5.5 $1.58 6/15/20231,130,000 shares $2.17 million +13.4%11.0%4.5 $1.92 5/31/2023996,900 shares $1.78 million +56.1%9.7%4.5 $1.79 5/15/2023638,800 shares $1.23 million +167.6%6.2%2.9 $1.92 4/30/20231,490,000 shares $774,800.00 +2.8%2.4%1.3 $0.52 4/15/20231,450,000 shares $745,445.00 -42.0%2.3%1 $0.51 3/31/20232,500,000 shares $1.48 million -18.6%4.0%0.9 $0.59 3/15/20233,070,000 shares $1.73 million +15.9%4.9%0.8 $0.56 2/28/20232,650,000 shares $1.86 million -27.0%4.4%0.4 $0.70 2/15/20233,630,000 shares $3.88 million -14.6%6.0%0.5 $1.07 1/31/20234,250,000 shares $4.76 million -24.9%7.4%0.6 $1.12 1/15/20235,660,000 shares $7.36 million +68.5%9.8%0.9 $1.30 12/30/20223,360,000 shares $1.31 million -21.5%5.8%0.6 $0.39 12/15/20224,280,000 shares $1.39 million +210.1%7.4%1 $0.33 11/30/20221,380,000 shares $531,300.00 +123.2%2.4%0.8 $0.39 11/15/2022618,200 shares $306,009.00 -34.6%1.1%0.3 $0.50 10/31/2022945,400 shares $426,375.40 -16.3%1.7%0.4 $0.45 10/15/20221,130,000 shares $541,835.00 +1.8%2.5%0.2 $0.48 9/30/20221,110,000 shares $592,962.00 -41.6%2.5%0.2 $0.53 9/15/20221,900,000 shares $1.64 million -20.8%4.2%0.3 $0.86 8/31/20222,400,000 shares $2.45 million -4.0%5.4%0.3 $1.02 8/15/20222,500,000 shares $3.98 million +5.9%5.7%0.2 $1.59 7/31/20222,360,000 shares $3.96 million +204.6%7.5%0.2 $1.68 7/15/2022774,800 shares $983,996.00 -28.9%2.5%0.1 $1.27 6/30/20221,090,000 shares $1.72 million -30.1%5.8%0.2 $1.58 6/15/20221,560,000 shares $2.78 million -54.5%8.3%0.3 $1.78 5/31/20223,430,000 shares $8.37 million +133.3%18.3%0.6 $2.44 5/15/20221,470,000 shares $6.21 million -96.7%7.9%0.8 $4.22 4/30/202245,070,000 shares $6.58 million +21.8%N/A1.6 $0.15 4/15/202237,000,000 shares $6.95 million +15.6%N/A1.3 $0.19 3/31/202232,010,000 shares $7.37 million +11.1%N/A1.1 $0.23 3/15/202228,820,000 shares $6.14 million +2.2%N/A1.1 $0.21 2/28/202228,200,000 shares $5.22 million +2.6%N/A1.1 $0.19 2/15/202227,480,000 shares $5.69 million +19.5%N/A1.5 $0.21 1/31/202223,000,000 shares $5.59 million +167.8%N/A1.3 $0.24 1/15/20228,590,000 shares $2.46 million -14.2%N/A0.5 $0.29 12/31/202110,010,000 shares $3.58 million +15.5%N/A0.6 $0.36 12/15/20218,670,000 shares $3.80 million +0.2%N/A0.5 $0.44 11/30/20218,650,000 shares $4.06 million +39.1%N/A0.5 $0.47 11/15/20216,220,000 shares $3.60 million -0.5%N/A0.4 $0.58 10/29/20216,250,000 shares $3.45 million -0.3%N/A0.5 $0.55 10/15/20216,270,000 shares $3.57 million -33.8%N/A0.5 $0.57 9/30/20219,470,000 shares $5.69 million -4.6%N/A0.8 $0.60 9/15/20219,930,000 shares $6.16 million -15.4%N/A0.8 $0.62 8/31/202111,730,000 shares $8.28 million -15.7%N/A1.1 $0.71 8/13/202113,920,000 shares $9.47 million -12.8%N/A1.2 $0.68 7/30/202115,960,000 shares $11.43 million +36.9%4.8%1.5 $0.72 7/15/202111,660,000 shares $11.50 million -35.6%3.5%1.1 $0.99 6/30/202118,110,000 shares $20.10 million +115.3%5.5%1.7 $1.11 6/15/20218,410,000 shares $11.19 million +44.8%2.6%0.8 $1.33 5/28/20215,810,000 shares $6.86 million +10.3%1.8%0.4 $1.18 5/14/20215,270,000 shares $5.11 million -7.4%N/A0.4 $0.97 4/30/20215,690,000 shares $6.54 million +24.5%N/A0.2 $1.15 4/15/20214,570,000 shares $4.98 million -18.8%N/A0.1 $1.09 3/31/20215,630,000 shares $7.04 million +44.0%N/A0.1 $1.25 3/15/20213,910,000 shares $4.97 million +132.7%N/A0.1 $1.27 2/26/20211,680,000 shares $2.05 million -64.6%N/A0 $1.22 2/12/20214,740,000 shares $9.48 million +57.0%N/A0.1 $2.00 1/29/20213,020,000 shares $2.96 million -31.8%N/A0.1 $0.98 1/15/20214,430,000 shares $4.24 million +58.2%N/A0.2 $0.96 12/31/20202,800,000 shares $1.91 million +388.5%N/A0.2 $0.68 12/15/2020573,200 shares $333,602.40 +31.6%N/A0.1 $0.58 11/30/2020435,500 shares $249,106.00 -45.0%N/A0.1 $0.57 11/15/2020791,500 shares $489,067.85 +1.3%N/A0.1 $0.62 10/30/2020781,000 shares $470,630.60 -19.1%N/A0.1 $0.60 10/15/2020964,900 shares $713,157.59 -2.8%N/A0.1 $0.74 9/30/2020992,600 shares $833,784.00 -48.6%N/A0 $0.84 9/15/20201,930,000 shares $1.55 million +25.3%N/A0.1 $0.80 8/31/20201,540,000 shares $1.36 million -16.8%N/A0.1 $0.89 8/14/20201,850,000 shares $1.89 million -35.8%N/A0.1 $1.02 7/31/20202,880,000 shares $3.72 million +100.0%N/A0.1 $1.29 7/15/20201,440,000 shares $819,360.00 -4.6%N/A0.1 $0.57 6/30/20201,510,000 shares $921,855.00 +100.9%N/A0.2 $0.61 6/15/2020751,600 shares $464,488.80 +46.3%N/A0.1 $0.62 5/29/2020513,800 shares $347,482.94 -44.8%N/A0.1 $0.68 5/15/2020931,300 shares $639,989.36 +135.6%N/A0.1 $0.69 4/30/2020395,300 shares $266,155.49 -49.2%N/A0 $0.67 4/15/2020778,700 shares $595,705.50 -58.6%N/A0.1 $0.77 3/31/20201,880,000 shares $1.30 million +1.2%N/A0.2 $0.69 3/13/20201,856,900 shares $1.34 million -43.6%21.8%0.2 $0.72 2/28/20203,290,000 shares $2.80 million +2,138.1%38.6%0.4 $0.85 2/14/2020147,000 shares $124,950.00 -69.6%1.7%0 $0.85 1/31/2020482,900 shares $434,610.00 -44.4%5.7%0.2 $0.90 1/15/2020868,700 shares $416,976.00 +741.8%10.2%0.5 $0.48 TNXP Short Interest - Frequently Asked Questions What is Tonix Pharmaceuticals' current short interest? Short interest is the volume of Tonix Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of December 15th, investors have sold 4,000,000 shares of TNXP short. 2.14% of Tonix Pharmaceuticals' shares are currently sold short. Learn More on Tonix Pharmaceuticals' current short interest. What is a good short interest percentage for Tonix Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.14% of Tonix Pharmaceuticals' floating shares are currently sold short. Is Tonix Pharmaceuticals' short interest increasing or decreasing? Tonix Pharmaceuticals saw a increase in short interest in December. As of December 15th, there was short interest totaling 4,000,000 shares, an increase of 151.6% from the previous total of 1,590,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tonix Pharmaceuticals' float size? Tonix Pharmaceuticals currently has issued a total of 186,894,000 shares. Some of Tonix Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tonix Pharmaceuticals currently has a public float of 186,890,000 shares. How does Tonix Pharmaceuticals' short interest compare to its competitors? 2.14% of Tonix Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tonix Pharmaceuticals: Eledon Pharmaceuticals, Inc. (1.50%), Aurora Cannabis Inc. (7.81%), Heron Therapeutics, Inc. (19.71%), Inhibrx, Inc. (12.07%), Atai Life Sciences (9.06%), DiaMedica Therapeutics Inc. (0.46%), Opthea Limited (0.12%), LifeVantage Co. (2.03%), Lexeo Therapeutics, Inc. (8.61%), Cardiff Oncology, Inc. (19.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.32 billion), Spotify Technology S.A. ($4.06 billion), Canadian Natural Resources Limited ($3.45 billion), Reddit, Inc. ($2.79 billion), International Paper ($2.70 billion), Cencora, Inc. ($2.27 billion), SoFi Technologies, Inc. ($2.21 billion), Lululemon Athletica Inc. ($2.13 billion), and Rivian Automotive, Inc. ($2.05 billion). View all of the most shorted stocks. What does it mean to sell short Tonix Pharmaceuticals stock? Short selling TNXP is an investing strategy that aims to generate trading profit from Tonix Pharmaceuticals as its price is falling. TNXP shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tonix Pharmaceuticals? A short squeeze for Tonix Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TNXP, which in turn drives the price of the stock up even further. How often is Tonix Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TNXP, twice per month. The most recent reporting period available is December, 15 2024. More Short Interest Resources from MarketBeat Related Companies ELDN Short Interest Data ACB Short Interest Data HRTX Short Interest Data INBX Short Interest Data ATAI Short Interest Data DMAC Short Interest Data OPT Short Interest Data LFVN Short Interest Data LXEO Short Interest Data CRDF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TNXP) was last updated on 1/6/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredFrom bankrupt to delivering 610,000% returnsWalk the empty streets of this barren town and you would have no idea that behind the sand-scarred blight is o...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBank of America just did this with NvidiaThanks to Nvidia’s continued AI dominance and reflecting its growth potential … Bank of America recently ma...Weiss Ratings | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
